Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Dosing commences in phase II study of STP-705 for keloid scar prevention

July 15, 2021

Escient reports phase I data on EP-547 for pruritus associated with cholestasis and uremia

July 15, 2021

HT-003 reduces expression of inflammatory cytokines in acne therapeutic model

July 15, 2021

FDA clears IND for Kintor's GT-20029 for androgenetic alopecia and acne

July 14, 2021

Tyrosine-protein kinase ITK/TSK inhibitors discovered at Pfizer

July 14, 2021

EscharEx debridement agent demonstrates efficiency, safety in chronic wound study

July 13, 2021

FDA clears initiation of phase II trial of pyrilutamide in androgenetic alopecia

July 12, 2021

Kymera reports interim phase I SAD data on IRAK-4 degrader KT-474

June 28, 2021

Follicum discontinues development of FOL-005 for alopecia

June 25, 2021

Kaken begins Japanese phase I study of sofpironium bromide gel in primary palmoplantar hyperhidrosis

June 25, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 28, 2025
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...